10mg Tirzepatide: How Many Units Does That Equal?

Each Mounjaro KwikPen is pre-filled and pre-set: the 10mg pen delivers exactly 10mg per weekly dose, no measuring, no drawing up.
Tirzepatide is not measured in insulin units; comparing the two directly can lead to confusion and, more seriously, dosing errors.
The licensed UK schedule runs from 2.5mg up through 5, 7.5, 10, 12.5 and 15mg, dose progression is guided by your prescriber, not self-directed.
Attempting to convert a Mounjaro dose into syringe units and self-administer outside the pen is unsafe and not how the medicine is licensed to be used.

The 10mg dose of tirzepatide (Mounjaro) equals 10 units on a standard insulin syringe marked in milligrams — because Mounjaro's KwikPen delivers a fixed volume, not a unit count that you measure yourself. Each pre-filled pen contains four 0.5ml doses, each pre-set to the labelled strength, so the 10mg pen gives exactly 10mg per weekly injection without any measuring on your part. That said, if you've seen unit values mentioned online and want to understand what they actually mean for this particular dose, the short answer is that tirzepatide is not drawn up in units the way insulin is — the pen does the maths. For anyone working out what 10mg tirzepatide looks like in unit terms, it helps to understand how the KwikPen system works, and why the comparison to insulin units is often misleading. These are prescription-only medicines; a GPhC-registered prescriber decides the right dose for each person after a full clinical assessment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the Units Question Matters, and What the Evidence Says About the 10mg Dose

Where the units question usually comes from

Most people asking this have experience with insulin, or they've seen compounded or unlicensed tirzepatide sold in vials online, where a syringe and unit markings are involved. It's a fair question, and an important safety one. Insulin syringes use a unit scale that has no direct equivalence to milligrams of tirzepatide, so converting between units and milligrams, even at a dose like 5mg, is not a straightforward calculation. The licensed Mounjaro KwikPen sidesteps all of this by delivering a pre-measured, fixed volume at the push of a button. You press, you hear the click, the dose is done.

If you're trying to understand the maths behind vial-based tirzepatide, it's worth knowing that unlicensed vials are not part of the authorised UK supply chain, and the MHRA has warned explicitly about the risks of tirzepatide sold outside that chain, including fake pens and unverified vials seized in large enforcement operations. Our FAQs cover the supply chain question in more detail.

For the licensed KwikPen, there is no unit conversion to do. The pen is set. That's the point of the design.

What the clinical evidence tells us about 10mg specifically

The 10mg dose sits in the upper-middle of Mounjaro's licensed range. In the SURMOUNT-1 trial (a 72-week study in over 2,500 adults with obesity, published in the New England Journal of Medicine) participants at the 10mg maintenance dose achieved meaningful average weight loss, with the 15mg group reaching approximately 20–21% average reduction overall. The 10mg dose produced substantial results in its own right, though individual outcomes varied considerably depending on adherence, lifestyle factors and starting weight.

What the trial also confirmed is that the dose progression matters. Participants started at 2.5mg (a level designed to let the body adjust rather than to produce weight loss) and moved upward in steps. Jumping straight to 10mg would have produced significantly more gastrointestinal side effects with no additional long-term benefit. The 5mg dose typically comes before 10mg in the titration sequence, and the prescriber decides the timing of each step based on how a person is tolerating the current dose.

NICE's appraisal of tirzepatide (TA1026) drew on this trial evidence when recommending the medicine for eligible adults on the NHS. The recommendation covers the full licensed range, not a specific dose, because the right maintenance dose is an individual clinical decision.

The KwikPen mechanism and why there's no unit to calculate

Each Mounjaro KwikPen contains four weekly doses. When you press the button, a fixed 0.5ml volume is injected subcutaneously, into the abdomen, thigh or upper arm, rotating sites each week. The concentration in each pen varies by strength so that the same 0.5ml always delivers the labelled milligram amount. At 10mg, that means 10mg every time, with no variation based on how you hold the pen or how quickly you inject.

For anyone curious about how this compares at other points on the titration ladder, the 7.5mg dose follows the same fixed-volume principle, as does every other strength. The pen cannot be partially depressed to give a smaller dose, and it is not designed to be emptied into a syringe. Attempting to do so would compromise sterility and almost certainly introduce dosing error.

If you want a fuller look at the general Mounjaro dose and treatment pathway, our Mounjaro overview covers the whole picture in plain language.

What a prescriber considers at the 10mg stage

Reaching 10mg means a person has already been on treatment for roughly 12 to 16 weeks. By this point, a prescriber reviewing your case (as happens at every repeat with a regulated online pharmacy) will be looking at how much weight has been lost, how the previous doses were tolerated, and whether there are any clinical reasons to pause titration rather than continue upward.

We know from the trial data and from NHS guidance on tirzepatide that gastrointestinal effects (nausea most commonly, sometimes vomiting or diarrhoea) tend to be most noticeable after a dose increase and often settle within a few weeks. At 10mg, some people find the GI effects more pronounced than at earlier steps; others tolerate it easily. The prescriber's job is to weigh that against the progression plan.

If you're wondering where you sit in that picture, or whether 10mg is the right next step for you, that's precisely the conversation a clinical review is for. The free consultation at nume is reviewed the same day by a named GPhC-registered prescriber, a real clinician, not an automated decision. We know that working out dosage questions online can feel frustrating when what you actually need is a direct answer from someone who knows your case. That's what the consultation is there for.

For broader context on how treatment costs sit alongside the clinical process, our Mounjaro pricing page explains what's included in a single transparent price.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions